跳转至内容
Merck
CN

57857

Lithium iodoacetate

≥97.0% (NT)

别名:

Iodoacetic acid lithium salt

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
ICH2COOLi
化学文摘社编号:
分子量:
191.88
UNSPSC Code:
12352103
NACRES:
NA.25
PubChem Substance ID:
EC Number:
265-905-7
Beilstein/REAXYS Number:
4208524
MDL number:
Assay:
≥97.0% (NT)
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Level

assay

≥97.0% (NT)

impurities

≤3% water

mp

239 °C (dec.) (lit.), ~245 °C (dec.)

SMILES string

[Li+].[O-]C(=O)CI

InChI

1S/C2H3IO2.Li/c3-1-2(4)5;/h1H2,(H,4,5);/q;+1/p-1

InChI key

RZCFQIDTJPHHFJ-UHFFFAOYSA-M

Application

Lithium iodoacetate, a halogenacetate, is a lithium salt of iodoacetate that may be used in the study of cysteine peptidases.

Other Notes

Sales restrictions may apply

Disclaimer

May discolor to yellow on storage


pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Ehrenberg et al.
Acta crystallographica. Section B, Structural science, 55(Pt 4), 517-524 (2000-08-06)
Most halogenoacetates of alkali salts readily undergo a thermally induced polymerization reaction to poly-(hydroxyacetic acid) in the solid state. The lithium salts represent a remarkable exception. The crystal structures of lithium chloroacetate, lithium bromoacetate and lithium iodoacetate were determined ab
Yun Ju Woo et al.
Experimental & molecular medicine, 43(10), 561-570 (2011-07-29)
Osteoarthritis (OA) is an age-related joint disease that is characterized by degeneration of articular cartilage and chronic pain. Oxidative stress is considered one of the pathophysiological factors in the progression of OA. We investigated the effects of grape seed proanthocyanidin
Sébastien Goutal et al.
Drug delivery and translational research, 8(3), 536-542 (2018-01-03)
Elacridar (GF120918) is a highly potent inhibitor of both P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2), the main efflux transporters expressed at the blood-brain barrier (BBB). Elacridar shows very low aqueous solubility, which complicates its formulation for i.v. administration.



全球贸易项目编号

货号GTIN
57857-50G-F04061832860398
57857-1KG-F04061832629223